We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+0.65%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$73.9B
AUM Growth
-$2.32B
(-3%)
Cap. Flow
-$2.03B
Cap. Flow
% of AUM
-2.75%
Top 10 Holdings %
Top 10 Hldgs %
22.54%
Holding
3,088
New
92
Increased
1,359
Reduced
1,564
Closed
46
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Moderna
MRNA
|
+$60.7M |
| 2 |
Analog Devices
ADI
|
+$46.1M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$37.3M |
| 4 |
Match Group
MTCH
|
+$28.2M |
| 5 |
GXO Logistics
GXO
|
+$19.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$89.3M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$78.9M |
| 3 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$77.4M |
| 4 |
Apple
AAPL
|
+$77M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$70.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.91% |
| 2 | Financials | 14.2% |
| 3 | Healthcare | 13.07% |
| 4 | Consumer Discretionary | 12.09% |
| 5 | Communication Services | 9.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1401
Eastern Bankshares
EBC
$5.23B
| $4.65M | 0.01% |
228,890
+7,340
| +3% | +$140K |
|
1402
Ionis Pharmaceuticals
IONS
$9.4B
| $4.64M | 0.01% |
138,363
-1,222
| -0.9% | -$46K |
|
|
CLDR
1403
DELISTED
Cloudera, Inc.
CLDR
| $4.64M | 0.01% |
290,576
+9,264
| +3% | +$147K |
|
1404
Century Communities
CCS
$2.03B
| $4.64M | 0.01% |
75,439
-10,635
| -12% | -$705K |
|
1405
MGE Energy Inc
MGEE
$3.08B
| $4.63M | 0.01% |
63,019
-3,948
| -6% | -$309K |
|
1406
Carpenter Technology
CRS
$28.4B
| $4.63M | 0.01% |
141,330
-19,045
| -12% | -$674K |
|
1407
Marten Transport
MRTN
$1.22B
| $4.58M | 0.01% |
292,147
+53,514
| +22% | +$839K |
|
1408
Herc Holdings
HRI
$5.61B
| $4.58M | 0.01% |
27,995
+265
| +1% | +$33.6K |
|
|
ESGR
1409
DELISTED
Enstar Group
ESGR
| $4.57M | 0.01% |
19,447
-818
| -4% | -$200K |
|
|
AQUA
1410
DELISTED
Evoqua Water Technologies Corp. Common Stock
AQUA
| $4.56M | 0.01% |
121,450
+447
| +0.4% | +$16.2K |
|
1411
OSI Systems
OSIS
$3.89B
| $4.56M | 0.01% |
48,071
-6,166
| -11% | -$600K |
|
1412
Veracyte
VCYT
$3.8B
| $4.54M | 0.01% |
97,630
+1,958
| +2% | +$85.4K |
|
|
ATRI
1413
DELISTED
Atrion Corp
ATRI
| $4.53M | 0.01% |
6,499
+798
| +14% | +$530K |
|
1414
AeroVironment
AVAV
$9.45B
| $4.52M | 0.01% |
52,367
-7,883
| -13% | -$763K |
|
1415
Beam Therapeutics
BEAM
$2.84B
| $4.52M | 0.01% |
51,941
+3,210
| +7% | +$322K |
|
1416
Q2 Holdings
QTWO
$3.92B
| $4.52M | 0.01% |
56,363
+455
| +0.8% | +$41.7K |
|
1417
Xencor
XNCR
$1.55B
| $4.52M | 0.01% |
138,269
-20,915
| -13% | -$687K |
|
1418
Capitol Federal Financial
CFFN
$1.1B
| $4.51M | 0.01% |
392,797
-48,197
| -11% | -$544K |
|
|
EPAY
1419
DELISTED
Bottomline Technologies Inc
EPAY
| $4.51M | 0.01% |
114,730
-14,594
| -11% | -$588K |
|
|
SPR
1420
DELISTED
Spirit AeroSystems
SPR
| $4.5M | 0.01% |
101,711
-10,342
| -9% | -$433K |
|
|
VRE
1421
DELISTED
Veris Residential
VRE
| $4.47M | 0.01% |
261,324
-41,243
| -14% | -$718K |
|
1422
iShares Core S&P Small-Cap ETF
IJR
$112B
| $4.47M | 0.01% |
40,945
-4,495
| -10% | -$495K |
|
|
EQC
1423
DELISTED
Equity Commonwealth
EQC
| $4.47M | 0.01% |
172,101
+3,162
| +2% | +$83.2K |
|
1424
BioCryst Pharmaceuticals
BCRX
$2.4B
| $4.47M | 0.01% |
310,759
+7,449
| +2% | +$117K |
|
1425
QuantumScape Corp
QS
$3.74B
| $4.45M | 0.01% |
181,263
+77,487
| +75% | +$1.77M |
|
Similar funds
VAM
RhumbLine Advisers's Q3 2021 Portfolio in Review
As of Q3 2021, RhumbLine Advisers held 3,088 positions worth $73.9B, down 3% from $76.2B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Trading was light in Q3 2021: portfolio turnover was 4.5%. RhumbLine Advisers opened 92 new positions and exited 46, leaving the 3,088-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.
- RhumbLine Advisers's largest Q3 2021 buy was GXO Logistics: 250,722 shares worth $19.7M.
- RhumbLine Advisers added most to Moderna in Q3 2021, an estimated $60.7M increase.
- RhumbLine Advisers's biggest Q3 2021 reduction was Microsoft, cutting an estimated $89.3M.
- RhumbLine Advisers fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $77.4M.
- RhumbLine Advisers's ten largest holdings make up 23% of its $73.9B portfolio in Q3 2021.
- RhumbLine Advisers opened 92 new positions and closed 46 in Q3 2021.
- RhumbLine Advisers's portfolio value fell 3% quarter-over-quarter to $73.9B.
Based on RhumbLine Advisers's 13F filing for Q3 2021, filed 12 Nov 2021.